![](/img/cover-not-exists.png)
Comparison of discontinuation risk in patients initiated on lisdexamfetamine dimesylate (LDX) vs. other medications for the treatment of attention deficit/hyperactivity disorder (ADHD): A retrospective claims analysis
Setyawan, J., Hodgkins, P., Guerin, A., Gauthier, G., Cloutier, M., Wu, E., Erder, M.H.Volume:
60
Language:
english
Journal:
Neuropsychiatrie de l'Enfance et de l'Adolescence
DOI:
10.1016/j.neurenf.2012.04.677
Date:
July, 2012
File:
PDF, 65 KB
english, 2012